Functional properties and evolutionary splicing constraints on a composite exonic regulatory element of splicing in CFTR exon 12

Nucleic Acids Research

Volumn 38, Issue 2, 2009, Pages 647-659

  Haque, Ariful ^a   Buratti, Emanuele ^a   Baralle, Francisco E ^a  

^a INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; SERINE; TRANSMEMBRANE CONDUCTANCE REGULATOR; CFTR PROTEIN, HUMAN; NUCLEAR PROTEIN; RNA BINDING PROTEIN; SERINE ARGININE RICH SPLICING PROTEINS; SERINE-ARGININE-RICH SPLICING PROTEINS;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; ENHANCER REGION; EXON; GENE TARGETING; GENETIC CONSERVATION; HUMAN; HUMAN CELL; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PROCESSING; REGULATORY SEQUENCE; SILENCER ELEMENT; SPECIES DIFFERENCE; ANIMAL; BINDING SITE; GENETICS; HELA CELL; METABOLISM; MOLECULAR EVOLUTION; MOLECULAR GENETICS; MUTATION; REGULATORY RNA SEQUENCE; RNA SPLICING;

ANIMALS; BASE SEQUENCE; BINDING SITES; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; EVOLUTION, MOLECULAR; EXONS; HELA CELLS; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEINS; HUMANS; MICE; MOLECULAR SEQUENCE DATA; MUTATION; NUCLEAR PROTEINS; REGULATORY SEQUENCES, RIBONUCLEIC ACID; RNA SPLICING; RNA-BINDING PROTEINS;

EID: 77449117599     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkp1040     Document Type: Article

References (67)

1. Pagani,F. and Baralle,F.E. (2004) Genomic variants in exons and introns: identifying the splicing spoilers. Nat. Rev. Genet., 5, 389-396.
2. Parmley,J.L. and Hurst,L.D. (2007) How do synonymous mutations affect fitness? Bioessays, 29, 515-519.
3. Chamary,J.V., Parmley,J.L. and Hurst,L.D. (2006) Hearing silence: non-neutral evolution at synonymous sites in mammals. Nat. Rev. Genet., 7, 98-108.
4. Black,D.L. (2003) Mechanisms of alternative pre-messenger RNA splicing. Annu. Rev. Biochem., 72, 291-336.
5. Mardon,H.J., Sebastio,G. and Baralle,F.E. (1987) A role for exon sequences in alternative splicing of the human fibronectin gene. Nucleic Acids Res., 15, 7725-7733.
6. Reed,R. and Maniatis,T. (1986) A role for exon sequences and splice-site proximity in splice-site selection. Cell, 46, 681-690.
7. Breathnach,R., Benoist,C., O'Hare,K., Gannon,F. and Chambon,P. (1978) Ovalbumin gene: evidence for a leader sequence in mRNA and DNA sequences at the exon-intron boundaries. Proc. Natl Acad. Sci. USA, 75, 4853-4857.
8. Ben-Dov,C., Hartmann,B., Lundgren,J. and Valcarcel,J. (2008) Genome-wide analysis of alternative pre-mRNA splicing. J. Biol. Chem., 283, 1229-1233.
9. Moore,M.J. and Silver,P.A. (2008) Global analysis of mRNA splicing. RNA, 14, 197-203.
10. Buratti,E. and Baralle,F.E. (2005) Another step forward for SELEXive splicing. Trends Mol. Med., 11, 5-9.
11. Chasin,L.A. (2007) Searching for splicing motifs. Adv. Exp. Med. Biol., 623, 85-106.
12. Wang,J., Smith,P.J., Krainer,A.R. and Zhang,M.Q. (2005) Distribution of SR protein exonic splicing enhancer motifs in human protein-coding genes. Nucleic Acids Res., 33, 5053-5062.
13. Pozzoli,U. and Sironi,M. (2005) Silencers regulate both constitutive and alternative splicing events in mammals. Cell. Mol. Life Sci., 62, 1579-1604.
14. Cartegni,L., Chew,S.L. and Krainer,A.R. (2002) Listening to silence and understanding nonsense: exonic mutations that affect splicing. Nat. Rev. Genet., 3, 285-298.
15. Blencowe,B.J. (2000) Exonic splicing enhancers: mechanism of action, diversity and role in human genetic diseases. Trends Biochem. Sci., 25, 106-110.
16. Venables,J.P. (2007) Downstream intronic splicing enhancers. FEBS Lett., 581, 4127-4131.
17. Wang,Z., Rolish,M.E., Yeo,G., Tung,V., Mawson,M. and Burge,C.B. (2004) Systematic identification and analysis of exonic splicing silencers. Cell., 119, 831-845.
18. Wang,Z. and Burge,C.B. (2008) Splicing regulation: from a parts list of regulatory elements to an integrated splicing code. RNA, 14, 802-813.
19. Lin,S. and Fu,X.D. (2007) SR proteins and related factors in alternative splicing. Adv. Exp. Med. Biol., 623, 107-122.
20. Huang,Y. and Steitz,J.A. (2005) SRprises along a messenger's journey. Mol. Cell., 17, 613-615.
21. Long,J.C. and Caceres,J.F. (2009) The SR protein family of splicing factors: master regulators of gene expression. Biochem. J., 417, 15-27.
22. Martinez-Contreras,R., Cloutier,P., Shkreta,L., Fisette,J.F., Revil,T. and Chabot,B. (2007) hnRNP proteins and splicing control. Adv. Exp. Med. Biol., 623, 123-147.
23. Venables,J.P., Koh,C.S., Froehlich,U., Lapointe,E., Couture,S., Inkel,L., Bramard,A., Paquet,E.R., Watier,V., Durand,M. et al. (2008) Multiple and specific mRNA processing targets for the major human hnRNP proteins. Mol. Cell. Biol., 28, 6033-6043.
24. Jurica,M.S. and Moore,M.J. (2003) Pre-mRNA splicing: awash in a sea of proteins. Mol. Cell., 12, 5-14.
25. Zhu,J., Mayeda,A. and Krainer,A.R. (2001) Exon identity established through differential antagonism between exonic splicing silencer-bound hnRNP A1 and enhancer-bound SR proteins. Mol. Cell., 8, 1351-1361.
26. Eperon,I.C., Makarova,O.V., Mayeda,A., Munroe,S.H., Caceres,J.F., Hayward,D.G. and Krainer,A.R. (2000) Selection of alternative 5′ splice sites: role of U1 snRNP and models for the antagonistic effects of SF2/ASF and hnRNP A1. Mol. Cell. Biol., 20, 8303-8318.
27. Caceres,J.F., Stamm,S., Helfman,D.M. and Krainer,A.R. (1994) Regulation of alternative splicing in vivo by overexpression of antagonistic splicing factors. Science, 265, 1706-1709.
28. Relogio,A., Ben-Dov,C., Baum,M., Ruggiu,M., Gemund,C., Benes,V., Darnell,R.B. and Valcarcel,J. (2005) Alternative splicing microarrays reveal functional expression of neuron-specific regulators in Hodgkin lymphoma cells. J. Biol. Chem., 280, 4779-4784.
29. Grosso,A.R., Gomes,A.Q., Barbosa-Morais,N.L., Caldeira,S., Thorne,N.P., Grech,G., von Lindern,M. and Carmo-Fonseca,M. (2008) Tissue-specific splicing factor gene expression signatures. Nucleic Acids Res., 36, 4823-4832.
30. Shin,C., Feng,Y. and Manley,J.L. (2004) Dephosphorylated SRp38 acts as a splicing repressor in response to heat shock. Nature, 427, 553-558.
31. Blaustein,M., Pelisch,F. and Srebrow,A. (2007) Signals, pathways and splicing regulation. Int. J. Biochem. Cell. Biol., 39, 2031-2048.
32. Huang,Y., Yario,T.A. and Steitz,J.A. (2004) A molecular link between SR protein dephosphorylation and mRNA export. Proc. Natl Acad. Sci. USA, 101, 9666-9670.
33. Misteli,T., Caceres,J.F., Clement,J.Q., Krainer,A.R., Wilkinson,M.F. and Spector,D.L. (1998) Serine phosphorylation of SR proteins is required for their recruitment to sites of transcription in vivo. J. Cell. Biol., 143, 297-307.
34. Buratti,E., Dhir,A., Lewandowska,M.A. and Baralle,F.E. (2007) RNA structure is a key regulatory element in pathological ATM and CFTR pseudoexon inclusion events. Nucleic Acids Res., 35, 4369-4383.
35. Buratti,E., Muro,A.F., Giombi,M., Gherbassi,D., Iaconcig,A. and Baralle,F.E. (2004) RNA folding affects the recruitment of SR proteins by mouse and human polypurinic enhancer elements in the fibronectin EDA exon. Mol. Cell. Biol., 24, 1387-1400.
36. Hiller,M., Zhang,Z., Backofen,R. and Stamm,S. (2007) Pre-mRNA secondary structures influence exon recognition. PLoS Genet., 3, e204.
37. Shepard,P.J. and Hertel,K.J. (2008) Conserved RNA secondary structures promote alternative splicing. RNA, 14, 1463-1469.
38. Cheah,M.T., Wachter,A., Sudarsan,N. and Breaker,R.R. (2007) Control of alternative RNA splicing and gene expression by eukaryotic riboswitches. Nature, 447, 497-500.
39. Graveley,B.R. (2005) Mutually exclusive splicing of the insect Dscam pre-mRNA directed by competing intronic RNA secondary structures. Cell., 123, 65-73.
40. Pagani,F., Raponi,M. and Baralle,F.E. (2005) Synonymous mutations in CFTR exon 12 affect splicing and are not neutral in evolution. Proc. Natl Acad. Sci. USA, 102, 6368-6372.
41. Parmley,J.L., Chamary,J.V. and Hurst,L.D. (2006) Evidence for purifying selection against synonymous mutations in mammalian exonic splicing enhancers. Mol. Biol. Evol., 23, 301-309.
42. Parmley,J.L. and Hurst,L.D. (2007) Exonic splicing regulatory elements skew synonymous codon usage near intron-exon boundaries in mammals. Mol. Biol. Evol., 24, 1600-1603
43. Irimia,M., Rukov,J.L. and Roy,S.W. (2009) Evolution of alternative splicing regulation: changes in predicted exonic splicing regulators are not associated with changes in alternative splicing levels in primates. PLoS ONE, 4, e5800.
44. Pagani,F., Stuani,C., Tzetis,M., Kanavakis,E., Efthymiadou,A., Doudounakis,S., Casals,T. and Baralle,F.E. (2003) New type of disease causing mutations: the example of the composite exonic regulatory elements of splicing in CFTR exon 12. Hum. Mol. Genet., 12, 1111-1120.
45. Pagani,F., Buratti,E., Stuani,C. and Baralle,F.E. (2003) Missense, nonsense, and neutral mutations define juxtaposed regulatory elements of splicing in cystic fibrosis transmembrane regulator exon 9. J. Biol. Chem., 278, 26580-26588.
46. Buratti,E., Baralle,M., De Conti,L., Baralle,D., Romano,M., Ayala,Y.M. and Baralle,F.E. (2004) hnRNP H binding at the 5′ splice site correlates with the pathological effect of two intronic mutations in the NF-1 and TSHbeta genes. Nucleic Acids Res., 32, 4224-4236.
47. Buratti,E., Dork,T., Zuccato,E., Pagani,F., Romano,M. and Baralle,F.E. (2001) Nuclear factor TDP-43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping. EMBO J., 20, 1774-1784.
48. Buratti,E. and Baralle,F.E. (2001) Characterization and functional implications of the RNA binding properties of nuclear factor TDP-43, a novel splicing regulator of CFTR exon 9. J. Biol. Chem., 276, 36337-36343.
49. Delaney,S.J., Rich,D.P., Thomson,S.A., Hargrave,M.R., Lovelock,P.K., Welsh,M.J. and Wainwright,B.J. (1993) Cystic fibrosis transmembrane conductance regulator splice variants are not conserved and fail to produce chloride channels. Nat. Genet., 4, 426-431.
50. Hull,J., Shackleton,S. and Harris,A. (1993) Abnormal mRNA splicing resulting from three different mutations in the CFTR gene. Hum. Mol. Genet., 2, 689-692.
51. Zielenski,J., Markiewicz,D., Lin,S.P., Huang,F.Y., Yang-Feng,T.L. and Tsui,L.C. (1995) Skipping of exon 12 as a consequence of a point mutation (1898 + 5G→T) in the cystic fibrosis transmembrane conductance regulator gene found in a consanguineous Chinese family. Clin. Genet., 47, 125-132
52. Strong,T.V., Smit,L.S., Nasr,S., Wood,D.L., Cole,J.L., Iannuzzi,M.C., Stern,R.C. and Collins,F.S. (1992) Characterization of an intron 12 splice donor mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Hum. Mutat., 1, 380-387.
53. Hartmann,L., Theiss,S., Niederacher,D. and Schaal,H. (2008) Diagnostics of pathogenic splicing mutations: does bioinformatics cover all bases? Front Biosci., 13, 3252-3272.
54. Houdayer,C., Dehainault,C., Mattler,C., Michaux,D., Caux-Moncoutier,V., Pages-Berhouet,S., d'Enghien,C.D., Lauge,A., Castera,L., Gauthier-Villars,M. et al. (2008) Evaluation of in silico splice tools for decision-making in molecular diagnosis. Hum. Mutat., 29, 975-982.
55. Auweter,S.D., Oberstrass,F.C. and Allain,F.H. (2006) Sequencespecific binding of single-stranded RNA: is there a code for recognition? Nucleic Acids Res., 34, 4943-4959.
56. Meyer,I.M. and Miklos,I. (2005) Statistical evidence for conserved, local secondary structure in the coding regions of eukaryotic mRNAs and pre-mRNAs. Nucleic Acids Res., 33, 6338-6348.
57. Cartegni,L., Hastings,M.L., Calarco,J.A., de Stanchina,E. and Krainer,A.R. (2006) Determinants of exon 7 splicing in the spinal muscular atrophy genes, SMN1 and SMN2. Am. J. Hum. Genet., 78, 63-77.
58. Kashima,T., Rao,N., David,C.J. and Manley,J.L. (2007) hnRNP A1 functions with specificity in repression of SMN2 exon 7 splicing. Hum. Mol. Genet., 16, 3149-3159.
59. Sharma,S., Falick,A.M. and Black,D.L. (2005) Polypyrimidine tract binding protein blocks the 5′ splice site-dependent assembly of U2AF and the prespliceosomal E complex. Mol. Cell., 19, 485-496.
60. Chou,M.Y., Underwood,J.G., Nikolic,J., Luu,M.H. and Black,D.L. (2000) Multisite RNA binding and release of polypyrimidine tract binding protein during the regulation of c-src neural-specific splicing. Mol. Cell., 5, 949-957.
61. Matter,N., Herrlich,P. and Konig,H. (2002) Signal-dependent regulation of splicing via phosphorylation of Sam68. Nature, 420, 691-695.
62. Matter,N., Marx,M., Weg-Remers,S., Ponta,H., Herrlich,P. and Konig,H. (2000) Heterogeneous ribonucleoprotein A1 is part of an exon-specific splice-silencing complex controlled by oncogenic signaling pathways. J. Biol. Chem., 275, 35353-35360.
63. Cheng,C. and Sharp,P.A. (2006) Regulation of CD44 alternative splicing by SRm160 and its potential role in tumor cell invasion. Mol. Cell. Biol., 26, 362-370.
64. Venables,J.P., Bourgeois,C.F., Dalgliesh,C., Kister,L., Stevenin,J. and Elliott,D.J. (2005) Up-regulation of the ubiquitous alternative splicing factor Tra2beta causes inclusion of a germ cell-specific exon. Hum. Mol. Genet., 14, 2289-2303.
65. Ladd,A.N., Stenberg,M.G., Swanson,M.S. and Cooper,T.A. (2005) Dynamic balance between activation and repression regulates pre-mRNA alternative splicing during heart development. Dev. Dyn., 233, 783-793.
66. Singh,N.N., Androphy,E.J. and Singh,R.N. (2004) An extended inhibitory context causes skipping of exon 7 of SMN2 in spinal muscular atrophy. Biochem. Biophys. Res. Commun., 315, 381-388.
67. Baralle,D., Lucassen,A. and Buratti,E. (2009) Missed threads. The impact of pre-mRNA splicing defects on clinical practice. EMBO Rep., 10, 810-816.